Dexmedetomidine sedation reduces the incidence of atrial fibrillation in mechanically ventilated patients with COVID-19 pneumonia: A randomized controlled trial - Egyptian Knowledge Bank - troweb

387923

Dexmedetomidine sedation reduces the incidence of atrial fibrillation in mechanically ventilated patients with COVID-19 pneumonia: A randomized controlled trial

Article

Last updated: 05 Jan 2025

Overview Similar Items

Article

Dexmedetomidine versus propofol in reducing atrial fibrillation after cardiac surgery

Article

Dexmedetomedine versus Standard Sedatives in Weaning from Mechanical Ventilation

Article

Dexmedetomidine versus haloperidol for prevention of delirium during non-invasive mechanical ventilation

Article

Use of dexemedetomidine–fentanyl versus midazolam–fentanyl for sedation during awake fiberoptic intubation: a randomized double-blind controlled study

Article

Dexmedetomidine added to propofol for drug-induced sleep endoscopy in adult patients with obstructive sleep apnea: Randomized controlled trial

Article

The role of dexmedetomidine in fast-track extubation for closed congenital heart surgery in children: a randomized double-blinded placebo-controlled trial

Article

The effect of dexmedetomidine on the inflammatory response in children undergoing repair of congenital heart disease: a randomized controlled clinical trial

Article

Dexmedetomidine versus propofol for sedation in stereotactic brain biopsy: a comparative study

Article

Safety and efficacy of dexmedetomidine sedation for elective fiberoptic bronchoscopy: A comparative study with propofol

Article

Dexmedetomidine versus midazolam sedation for autistic children undergoing electroencephalogram: a prospective randomized trial